第一单位：
Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA.
作者：
Viviane M,Andrade [1]
;
Kathleen,Cashman [2]
;
Kyle,Rosenke [3]
;
Eric,Wilkinson [2]
;
Nicole,Josleyn [2]
;
Ginger,Lynn [2]
;
Jesse,Steffens [2]
;
Sean,Vantongeren [2]
;
Jay,Wells [2]
;
Connie,Schmaljohn [4]
;
Paul,Facemire [5]
;
Jingjing,Jiang [1]
;
Jean,Boyer [1]
;
Aditya,Patel [1]
;
Friederike,Feldmann [6]
;
Patrick,Hanley [6]
;
Jamie,Lovaglio [6]
;
Kimberly,White [3]
;
Heinz,Feldmann [3]
;
Stephanie,Ramos [1]
;
Kate E,Broderick [1]
;
Laurent M,Humeau [1]
;
Trevor R F,Smith [7]
作者单位：
Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA.
[1]
Virology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD, USA.
[2]
Laboratory of Virology (LV), Division of Intramural Research (DIR), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rocky Mountain Laboratories (RML), Hamilton, MT, USA.
[3]
Office of the Chief Scientists, Headquarters, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.;National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Integrated Research Facility (IRF), Frederick, MD, USA.
[4]
Pathology Division, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, MD, USA.
[5]
Rocky Mountain Laboratory Veterinary Branch (RMVB), Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rocky Mountain Laboratories (RML), Hamilton, MT, USA.
[6]
Inovio Pharmaceuticals Inc., Plymouth Meeting, PA, USA. Trevor.Smith@inovio.com.
[7]
DOI
10.1038/s43856-024-00684-8
PMID
39609515
发布时间
2024-12-01
换一批
